Cover image of Medtech Talk
(25)
Business
Investing
Health & Fitness

Medtech Talk

Updated 2 days ago

Business
Investing
Health & Fitness
Read more

A weekly conversation with the innovators who will change how health care is delivered.

Read more

A weekly conversation with the innovators who will change how health care is delivered.

iTunes Ratings

25 Ratings
Average Ratings
18
4
2
0
1

Great podcast

By Catherine.cookie - Jul 13 2019
Read more
Great for anyone looking to learn more about medical technologies/ current Med tech news

Medtech Investor

By MJ12345! - Mar 14 2019
Read more
Love the interview content. Well rounded and interesting. Always learn something new

iTunes Ratings

25 Ratings
Average Ratings
18
4
2
0
1

Great podcast

By Catherine.cookie - Jul 13 2019
Read more
Great for anyone looking to learn more about medical technologies/ current Med tech news

Medtech Investor

By MJ12345! - Mar 14 2019
Read more
Love the interview content. Well rounded and interesting. Always learn something new

The Best Episodes of:

Cover image of Medtech Talk

Medtech Talk

Updated 2 days ago

Read more

A weekly conversation with the innovators who will change how health care is delivered.

Rank #1: Justin Klein, MD, JD, Partner at New Enterprise Associates

Podcast cover
Read more
Justin Klein, MD, JD, sits down with Healthegy TV to provide details on where his firm, New Enterprise Associates, sees the greatest opportunities in Medtech. He also explains how a firm with $3 billion to manage still makes early-stage investments.

Feb 29 2016

24mins

Play

Rank #2: Healthegy's Medtech Conference Bringing Together Pols, VCs and Executives to Discuss Sector's Future

Podcast cover
Read more
Join us on Thursday at the Medtech Conference in Minneapolis to hear from Congressman Erik Paulsen.

A longtime proponent of the Medtech industry, Rep. Paulsen most recently co-authored a letter asking the Trump administration to remove medical technology products from a list of Chinese imports subject to protective tariffs.

The five-term Congressman also has fought against the Medical Device Tax.

The Medtech Conference co-chairs and advisory board also are pleased to honor Dave Amerson, CEO of NeoTract, as the recipient of this year’s Dealmaker of the Year Award.

The award recognizes Amerson's leadership of the urology start-up as it established its UroLift System as a critical treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.

Sales of UroLift were surging when Teleflex agreed to acquire the company, paying $725 million up front with the promise of another $375 million in milestone payments over the next two years.

In an interview, Justin Klein, general partner of NEA, and Amerson will discuss:
  • The steps Neotract took to adopt a winning culture?
  • What strategies helped the company secure support from payers, providers?
  • How the deal with Teleflex came to be?
  • What's next for Teleflex in Urology?

Join us on May 31st to explore this singular successful story and to better understand our entire Medtech sector.

May 29 2018

7mins

Play

Rank #3: We Ask Anders Wold, Head of GE’s Clinical Care Solutions, Where GE Fits in Healthcare’s Future

Podcast cover
Read more
Anders Wold, president and CEO of GE’s Clinical Care Solutions, is still fascinated by the power new technology can deliver to healthcare. So he’s understandably excited about the opportunities facing this division of GE – and the entire company as well – as we move into healthcare of the future.

Dec 15 2017

33mins

Play

Rank #4: Go Go Go! Scott Huennekens Explains How Strong Bias to Action Defined Leadership at Volcano, Verb

Podcast cover
Read more

Anyone who has swapped emails with Scott Huennekens has seen the Go Go Go signature at the bottom. They’re three little words, but they say so much about the special brand of enthusiasm Huennekens brings to leading companies like Digirad, Volcano, and most recently, Verb, the partnership between Google and Johnson & Johnson. In this podcast, Huennekens explains what he learned about maintaining momentum in Medtech. When is grit misplaced? When is hopping on a plane to Europe with no plan in hand a good idea? Huennekens will bring his insights to the Medtech Conference on May 29–30.

Apr 05 2019

49mins

Play

Rank #5: HealthQuest’s Kong on teamwork, Medtech, and investing $225 million

Podcast cover
Read more
HealthQuest Capital secured a $225 million fund to invest in new health care technologies. Managing Director Garheng Kong, MD, explains the firm’s views on health care, how doctors view new technologies and what competitive volleyball can teach us about venture investing.

Mar 30 2016

26mins

Play

Rank #6: FundRx Finding the Formula to Bring LPs, VCs, Individuals to Fund Promising Medtech Start-Ups

Podcast cover
Read more
Zeshan Muhammedi thinks he and his co-founders of FundRx have identified some “misalignments” in funding Medtechs. The solution may be FundRx, a new breed of venture capital firm bringing LPs, KOLs, and entrepreneurs on the same page.

Feb 24 2017

34mins

Play

Rank #7: Klein Shares how NEA Plans to Put More Than $300 Million to Work in Medtech Companies

Podcast cover
Read more
This week, New Enterprise Associates – known to its friends as NEA – announced closing on a $3.3 billion venture capital fund, with roughly 10% of that total going to Medtech companies. We asked partner Justin Klein, MD, how might the $300 million or so invest in Medtech companies be deployed differently than in the prior fund.

Jun 26 2017

12mins

Play

Rank #8: Norwest’s Mittendorff Details Past Successes and Future Challenges Facing Healthcare Technology

Podcast cover
Read more
Medtech and Digital Health technology increasingly have more and more in common. In this Medtech Talk Podcast, Robert Mittendorff, MD, a partner at Norwest Venture Partners, explains how Digital Health companies are facing many of the same challenges that vex Medtech start-ups, including the need to obtain approval under new FDA guidelines and to secure reimbursement payments from insurers

Nov 17 2017

38mins

Play

Rank #9: Newly Minted VC Stacy Enxing Seng Talks Medtech, Medtronic & Why She Joined Lightstone

Podcast cover
Read more
Though initially surprised by Medtronic’s move to buy Covidien, Stacy Enxing Seng says she immediately saw the wisdom of the deal and recognized the opportunity for a fresh start. In an interview, Enxing Seng explains why she left, what she’s been doing, and how her new role at Lightstone Ventures fits her vision for Medtech’s future.

Apr 28 2016

25mins

Play

Rank #10: How Will Abbott & Auris Deals Impact Early Stage Start-ups?

Podcast cover
Read more
Abbott’s move to acquire St. Jude demonstrates how Medtronic’s moves toward “Total Solutions” may change the game in Medtech. We’re going to tackle that topic at the June 1 Medtech Conference. Our conference co-chairs discuss that piece of our upcoming agenda as well as our focus on robotics.

May 03 2016

21mins

Play

Rank #11: Stanford’s Yock Talks Medtech Costs, Biodesign’s Birthday, and How He Feels about Apple and Google

Podcast cover
Read more
Paul Yock, MD, started Stanford’s Byers Center for Biodesign to help teach innovation. While the idea didn’t excite everyone, the center has emerged as the hub of entrepreneurial excellence. Dr. Yock speaks to the role of innovation and how it impacts Medtech.

May 03 2017

25mins

Play

Rank #12: Surgeon/Engineer Steve Charles Has Advice for Aspiring Inventors: Never Stop Learning; Dump Netflix

Podcast cover
Read more
Ask renowned vitreoretinal surgeon and inventor Steve Charles, MD, if he considers himself a surgeon or engineer first and he’ll answer – both. In this podcast, Dr. Charles says the terms “inventor” and “innovator” aren’t job titles. Innovation and inventing are what you get when insightful people commit themselves to a lifetime of learning in engineering and medicine. He gives his view of the future of innovation in the US. Here’s a hint: You won’t need to wear shades.

Jun 29 2018

35mins

Play

Rank #13: Relievant CEO Kevin Hykes Shares the Advice that Led Him to Set a Successful Course as CEO

Podcast cover
Read more
Under CEO Kevin Hykes, Relievant Medsystems is racking up some wins. The company closed on a $58 million Series E round last month and this week announced the first commercial application of its Intraspect pain-relief procedure. In this podcast, Hykes doles out some valuable career advice for wanna be CEOs and talks about the technology that could turn Relievant into a Medtech powerhouse.

Jul 13 2018

37mins

Play

Rank #14: Stanford’s Blumenkranz Delivers His State of Innovation Address. Spoiler: It Includes Lasers

Podcast cover
Read more
Serial innovator Mark Blumenkranz, MD, who last year moved into an emeritus position at Stanford, shares his enthusiasm and concerns for the future of innovation in the US.

Apr 13 2017

27mins

Play

Rank #15: Merit Medical CEO Fred Lampropoulos Lays Out Aggressive Growth Strategy, Including Opportunistic M&A

Podcast cover
Read more

Spoiler Alert: I missed a huge part of Merit Medical CEO Fred Lampropoulos’ life story when I did my research. I won’t say what it was, but you’ll hear it at the end. I’d fire my researcher if I had one, but instead I’ll just throw myself at the mercy of the Medtech Talk Podcast community. The good news, however, is that the thing that I missed – which would have removed Fred from Merit – didn’t happen, so he’s been able to build a multibillion-dollar Medtech that’s scooping up smaller players in the space. Fred’s an engaging fellow and we covered a lot of ground, including: 

  • What is Merit looking for in an acquisition target?
  •  How does Lampropoulos manage a publicly traded Medtech?
  •  Why doesn’t Utah have more Medtech start-ups? 
  •  And finally, what does Lampropoulous have to say about the spate of bad press Medtech has been getting lately?


At the Medtech Conference on May 29–30 hear from CEOs who have led their companies through an IPO and learn what they must do to thrive on the public markets, in the panel – How to Build for an IPO … and Beyond.

Panelists include:

Joe Army, President & CEO - Vapotherm
Tim Herbert, President & CEO - Inspire Medical Systems
Gerald R. Mattys, CEO - Tactile Medical

Feb 14 2019

42mins

Play

Rank #16: Optum’s Clark Says Medtechs Need to Craft Effective Message to Win Support from Payers and Providers

Podcast cover
Read more
Steve Clark, senior vice president at Optum Life Sciences, says healthcare rests in the “nascent” stages of questioning effectiveness of medical tech. Successful start-ups will find the right answers to those questions.

Feb 05 2017

17mins

Play

Rank #17: CEO Randall Recalls the Tale of Trans1 and Explains Why Omnilife Will Make Its Mark in Orthopedics

Podcast cover
Read more
Rick Randall’s initial foray into leading a Medtech company represented a bit of a fairy tale. But his next chapter – starting and leading spine company Trans1 – serves as a bit of a Medtech nightmare.

Apr 28 2017

39mins

Play

Rank #18: Managing Director Kirk Nielsen Talks Origins, Medtech, and Versant Ventures’ new $400 Million Fund

Podcast cover
Read more
Kirk Nielsen’s path to Versant passed through thoughts of medical school, a short stint in the NHL, and a span at Medtronic. Today, Nielsen represents the global VC’s interests in Medtech, serving as part of a new generation of partners taking over from the VC giant’s founders.

Mar 17 2017

29mins

Play

Rank #19: CEO Jim Buck Says Mardil Medical is Using Familiar Script to Rewrite the Rules on Treating FMR

Podcast cover
Read more
Jim Buck, President and CEO of Mardil Medical, shares his personal and professional Medtech stories. The common thread? He doesn't give up. One result may be Mardil pushing for the rebirth of a once high-flying Medtech technology.

In this podcast you'll hear:

  • His tragic, but uplifting path to Medtech.
  • Where his first stint as CEO went wrong.
  • How he came to Mardil.
  • How he believes Mardil will succeed where others haven't.

Mar 27 2018

52mins

Play

Rank #20: Mark Gelfand, Howard Levin Discuss Coridea, Ardian and How They’re Innovating Medtech Innovation

Podcast cover
Read more

Over the past decade, no other Medtech start-up has moved markets as much or as quickly as Ardian, the godfather of the renal denervation surge a decade ago. But the gold rush dried up in 2014 when Medtronic delivered disappointing clinical trial news that left many to declare “Renal Denervation is Dead.” Well, if we may borrow from Monty Python, renal denervation is not dead yet.  In this two-part podcast, we talk with Mark Gelfand and Howard Levin, the principals of Coridea, who developed Ardian’s approach. We'll talk with them about their path to creating Coridea, the state of innovation, and, of course, how the Ardian “Opera” influenced them going forward.

Apr 29 2019

30mins

Play